These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11113909)

  • 1. Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities.
    Weinans MJ; Butler SA; Mantingh A; Cole LA
    Prenat Diagn; 2000 Dec; 20(12):976-8. PubMed ID: 11113909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
    Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
    Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
    Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening.
    Cole LA; Omrani A; Cermik D; Singh RO; Mahoney MJ
    Prenat Diagn; 1998 Sep; 18(9):926-33. PubMed ID: 9793975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for down syndrome: preliminary results of an observational study on fresh samples.
    Palomaki GE; Knight GJ; Roberson MM; Cunningham GC; Lee JE; Strom CM; Pandian R
    Clin Chem; 2004 Jan; 50(1):182-9. PubMed ID: 14709646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal urinary beta-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy.
    Hayashi M; Kozu H
    Prenat Diagn; 1995 Jan; 15(1):11-6. PubMed ID: 7537878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay.
    Spencer K; Talbot JA; Abushoufa RA
    Prenat Diagn; 2002 Aug; 22(8):656-62. PubMed ID: 12210572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.
    Palomaki GE; Neveux LM; Knight GJ; Haddow JE; Pandian R
    Clin Chem; 2004 Oct; 50(10):1804-8. PubMed ID: 15319323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders. The Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1992 Jun; 12(6):495-504. PubMed ID: 1387477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome.
    Cuckle HS; Shahabi S; Sehmi IK; Jones R; Cole LA
    Prenat Diagn; 1999 Oct; 19(10):918-20. PubMed ID: 10521815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
    Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L
    Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated second-trimester maternal urine free beta-human chorionic gonadotropin levels in Asian pregnancies with fetal chromosomal abnormalities.
    Hsu JJ; Hung TH; Liou JD; Hsieh TT; Soong YK
    Fetal Diagn Ther; 1998; 13(6):352-6. PubMed ID: 9933818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening.
    Palomaki GE; Knight GJ; Neveux LM; Pandian R; Haddow JE
    Clin Chem; 2005 Aug; 51(8):1499-504. PubMed ID: 15961547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia.
    Keikkala E; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
    Placenta; 2013 Nov; 34(11):1059-65. PubMed ID: 23993394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
    Wright D; Spencer K; Kagan K K; Tørring N; Petersen OB; Christou A; Kallikas J; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
    Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
    Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal urinary beta-core hCG in chromosomally abnormal pregnancies in the first trimester.
    Kornman LH; Morssink LP; Wortelboer MJ; Beekhuis JR; De Wolf BT; Pratt JJ; Mantingh A
    Prenat Diagn; 1997 Feb; 17(2):135-9. PubMed ID: 9061761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
    Spencer K; Crossley JA; Aitken DA; Nicolaides KH
    Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
    Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.